 AUSTIN, Texas--BUSINESS WIRE--Savara Inc. Nasdaq: SVRA, a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to two new employees. On September 2, 2021, the Compensation Committee of Savaras Board of Directors granted inducement awards to two new employees who recently joined the Company. The inducement awards consist of options to purchase an aggregate of 200,000 shares of the Companys common stock and restricted 